IRIS
DEROSA, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.610
EU - Europa 10.418
AS - Asia 8.717
SA - Sud America 35
AF - Africa 32
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 15
Totale 33.849
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.445
CN - Cina 8.032
IE - Irlanda 2.933
UA - Ucraina 2.500
FI - Finlandia 1.421
DE - Germania 1.393
IT - Italia 791
SE - Svezia 768
SG - Singapore 516
GB - Regno Unito 309
CA - Canada 149
FR - Francia 93
IN - India 51
NL - Olanda 44
RU - Federazione Russa 44
IR - Iran 30
BE - Belgio 21
GR - Grecia 17
MU - Mauritius 17
IQ - Iraq 16
RO - Romania 16
EU - Europa 15
JP - Giappone 15
PE - Perù 15
MX - Messico 14
NZ - Nuova Zelanda 14
CH - Svizzera 11
ES - Italia 11
BR - Brasile 10
EG - Egitto 9
MK - Macedonia 9
TH - Thailandia 9
TR - Turchia 9
AU - Australia 8
CZ - Repubblica Ceca 8
JO - Giordania 6
PK - Pakistan 6
CO - Colombia 5
DZ - Algeria 5
MY - Malesia 5
CL - Cile 4
KR - Corea 4
PL - Polonia 4
AT - Austria 3
HK - Hong Kong 3
HU - Ungheria 3
LV - Lettonia 3
PT - Portogallo 3
RS - Serbia 3
BG - Bulgaria 2
EE - Estonia 2
KG - Kirghizistan 2
LT - Lituania 2
PH - Filippine 2
SI - Slovenia 2
UZ - Uzbekistan 2
AZ - Azerbaigian 1
BD - Bangladesh 1
BH - Bahrain 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MA - Marocco 1
PA - Panama 1
SA - Arabia Saudita 1
VE - Venezuela 1
YE - Yemen 1
Totale 33.849
Salva come PNG Salva come JPEG
Città #
Jacksonville 3.394
Dublin 2.933
Chandler 2.846
Nanjing 2.508
Boardman 1.097
Nanchang 1.091
Ashburn 826
Princeton 807
Shenyang 758
Hebei 702
Lawrence 700
Changsha 664
Wilmington 655
Jiaxing 571
Medford 521
Hangzhou 426
Tianjin 414
Singapore 308
Beijing 284
Helsinki 247
Milan 140
Ann Arbor 138
Toronto 126
Shanghai 118
Woodbridge 115
Norwalk 111
Seattle 105
Fairfield 78
Kunming 66
Des Moines 61
Jinan 60
Cambridge 54
New York 53
Ningbo 51
Pavia 40
Verona 40
Los Angeles 39
Zhengzhou 35
Orange 30
Pune 27
Guangzhou 26
Eindhoven 24
Rome 22
Bruino 19
Brussels 19
Genova 18
Lanzhou 18
Taizhou 18
Piscataway 16
Redwood City 16
Washington 16
Dearborn 15
Fuzhou 15
Baghdad 14
Magenta 14
Changchun 13
Tokyo 13
Bologna 12
San Francisco 12
Frankfurt am Main 11
Houston 10
Paris 10
Timisoara 10
Dallas 8
Falkenstein 8
Leawood 8
Quzhou 8
Redmond 8
Skopje 8
Tappahannock 8
Trujillo 8
West Jordan 8
Auckland 7
Bangkok 7
Lima 7
Moscow 7
Rotterdam 7
Vancouver 7
Amman 6
Berlin 6
Borås 6
Brno 6
Florence 6
Haikou 6
Walnut 6
Zurich 6
Auburn Hills 5
Bogotá 5
Brescia 5
Caccamo 5
Chicago 5
Mumbai 5
Novokuznetsk 5
Palermo 5
Rozzano 5
Sacramento 5
Shah Alam 5
St Petersburg 5
Alcobendas 4
Andover 4
Totale 23.830
Salva come PNG Salva come JPEG
Nome #
Effetto del lactobacillus paracasei I1688 e del lactobacillus salivarius I1794 (psmix®) sui lipidi ematici nell’ipercolesterolemia lieve 315
Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial 148
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 145
A randomized, placebo-controlled study about the effect of a nutraceutical combination of red yeast rice, silybum marianum and octasonol on lipid profile, endothelial and inflammatory parameters 125
Diagnostico y Tratamiento de los desordenes lipidicos. Mc Graw Hill Education 2014. 95
Comparison between diet, orlistat and fluvastatin in obese patients with mild hypertension and hypercholesterolemia 86
Comparison between orlistat and sibutramine in obese patients with type 2 diabetes mellitus 84
Confronto tra dieta, orlistat e fluvastatina in soggetti obesi, con ipertensione arteriosa lieve e ipercolesterolemia 81
Effect of valsartan or olmesartan addition to amlodipine/hydrochlorotiazide combination on 24 hour blood pressure reduction in essential hypertension 80
Effects of berberis aristata/silybum marianum association on metabolic parameters and adipocytokines in overweight dyslipidemic patients 79
Diarrea in paziente diabetico 78
Differential effect of candesartan and olmesartan on adipose tissue activity biomarkers in type 2 diabetic hypertensive patients 77
A possible way to improve the glycemic control and the beta cell function during three years: the triple therapy. 77
Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes 76
Comparison between exenatide and glimepiride on metabolic control and on insulin resistance in type 2 diabetic patients with metformin therapy 75
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 74
A multicenter, randomised, single-blind study on the effects of exenatide or glimepiride on insulin resistance. 74
Alkaloids in the nature: pharmacological applications in clinical practice of berberine and mate tea. 74
Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes 73
Matrix metalloproteinase 2 may be a marker of microangiopathy compared to metalloproteinase 9 in children and adolescents with type 1 diabetes mellitus: A 5 year follow-up study 73
Confronto tra nateglinide più metformina rispetto a glibenclamide più metformina sul metabolismo glucidico nei pazienti diabetici di tipo 2: studio ad 1 anno 73
Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria 72
Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study 72
Azione della moxonidina sul metabolismo glucidico e lipidico negli ipertesi con sindrome metabolica 72
Confronto tra pioglitazone e rosiglitazone sul metabolismo glucidico e lipidico nei soggetti diabetici di tipo 2 in terapia con metformina 72
n-3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia 71
Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome 70
Association between low-molecular weight apolipoprotein(a) isoforms and obesity in Italian women 70
Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients 70
Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus 69
Are there light and serious metabolic syndromes? The need for a graded diagnosis. 69
Confronto tra l'effetto anti-proteinurico dell'associazione telmisartan/amlodipina rispetto a losartan/amlodipina nel paziente con diabete di tipo 2, iperteso e microalbuminurico 68
Actions of glimepiride plus metformin compared to rosiglitazone plus metformin on glucose metabolism, fibrinolytic, and coagulation measurements in Type 2 diabetic patients. 68
Comparison between orlistat and sibutramine in obese patients with mild hypertension 67
Il controllo del paziente dislipidemico 67
Berberis aristata/silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients 67
Effects of losartan and amlodipine alone or combined with simvastatin in hypertensive patients with nonalcoholic hepatic steatosis 67
Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load 67
Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients 66
Different actions of losartan and ramipril on adipose tissue Activity and vascular remodeling biomarkers in hypertensive patients 66
Prevenzione della malattia coronarica: il rischio cardiovascolare globale 66
n-3 PUFAs on metalloproteinases, inflammatory and insulin resistance parameters in dyslipidemic patients after euglycemic clamp and oral fat load. 66
A comparison between sitagliptin or glibenclamide in addition to metformin+pioglitazone on glycemic control and beta-cell function: the triple oral therapy 66
Effects of berberine on lipid profile in subjects with low cardiovascular risk 66
Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses. 66
Comparison between fosinopril and eprosartan on lipid profile and Lp(a) in normotensive, type 2 diabetic subjects, with microalbuminuria 65
Changes during glimepiride plus rosiglitazone vs glibenclamide plus rosiglitazone treatment on glucose metabolism and lipoprotein (a) in Type 2 diabetic patients. 65
Matrix metalloproteinase-2 activity (MMP-2) in children and adolescents with type 1 diabetes mellitus: Follow-up study 65
Sitagliptin added to previously taken anti-diabetic agents on insulin resistance and lipid profile: a two years study evaluation. 65
Aerobic physical activity in obese subjects compared to anaerobic/aerobic physical activity 65
Effects of rosiglitazone alone and in association with simvastatin on lipid and lipoprotein parameters in patients with metabolic syndrome 65
Long-term predictors of impaired fasting glucose and type 2 diabetes in subjects with family history of type 2 diabetes: A 12-years follow-up of the Brisighella Heart Study historical cohort. 65
Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome 64
Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients 64
Effects of sibutramine plus L-carnitine compared to sibutramine on inflammatory parameters in type 2 diabetic patients 64
Prognostic value of dypiridamole stress echocardiography for detection of silent myocardial ischemia in asymptomatic diabetic patients. 64
Vildagliptin added to metformin on β-cell function after an euglycemic hyperinsulinemic and hyperglycemic clamp in type 2 diabetic patients. 64
Coenzyme Q10 effect on the serum creatinine increase associated to rosuvastatin 20 mg in severe hypercholesterolemic patients 64
Effetti metabolici di telmisartan e irbesartan nei pazienti diabetici di tipo 2 con sindrome metabolica trattati con rosiglitazone 64
The efficacy and safety of pioglitazone or rosiglitazone added onto metformin on diabetic dyslipidemia 64
Effect of manidipine-rosuvastatin combination on fibrinolysis, inflammation markers and insulin sensitivity in hypertensive hypercholesterolemic patients 64
Comparison between perindopril and candesartan in hypertensive patients with type 2 diabetes: evaluation of lipid profile and Lp(a) 64
Canrenone on cardiovascular mortality in congestive heart failure: CanrenOne eFFects on cardiovascular mortality in patiEnts with congEstIve hearT failure: The COFFEE-IT study 63
Acarbose compared to placebo on insulin resistance biomarkers in a double-blind, placebo-controlled trial 63
Metalloproteasi-2, metalloproteasi-9 ed inibitore tissutale delle metalloproteasi-1 in pazienti ipertesi 63
La terapia delle dislipidemie come fattore di rischio cardiovascolare 63
A nutraceutical based approach to reduce cholesterolaemia in patients previously intolerant of more than a statin: a pilot study 63
Berberis aristata/Silybum marianum fixed combination (Berberol®) effects on lipid profile in dyslipidemic patients intolerant to statins at high dosages: A randomized, placebo-controlled, clinical trial. 63
La doxazosina migliora i parametri pressori e l'assetto metabolico nei soggetti intolleranti al glucosio in terapia con acarbose 63
Dietary habits in type II diabetes mellitus: how is adherence to dietary recommendations? 63
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial 63
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance (Clinical and Experimental Medicine, (2021), 10.1007/s10238-020-00679-4) 63
Effect of Fosinopril on blood pressure, lipid profile and lipoprotein (a) in normotensive patients with type 2 diabetes and microalbuminuria: open-label, uncontrolled study 62
Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation 62
Effect of losartan irbesartan and candesartan on platelet aggregability and fibrinolysis in type 2 diabetic hypertensive patients 62
Atorvastatin addition to losartan or to atenolol and recurrence of paroxysmal atrial fibrillation in hypertension 62
Fosinopril vs eprosartan in normotensive, Type 2 diabetic patients, with microalbuminuria 62
Dipyridamole echocardiography for detection of angiographically assessed coronary artery disease in asymptomatic type 2 diabetic patients: preliminary results of the SEDIA trial 62
Comparison between glimepiride plus pioglitazone vs. glimepiride plus rosiglitazone on glucose metabolism and on lipid, lipoprotein and apolipoprotein fractions in type 2 diabetic patients 62
A comparison study of Lp(a) plasma levels distribution between normo and hypertensive subjects with high BMI 62
Azione della moxonidina sul metabolismo glucidico e lipidico negli ipertesi con sindrome metabolica 62
Adipocytokines levels in obese and non-obese subjects, an observational study 62
Olmesartan/amlodipine combination vs olmesartan or amlodipine monotherapies on blood pressure and insulin resistance in a sample of hypertensive patients 62
Pioglitazone plus glimepiride: a promising alternative in metabolic control 62
Intervento multi-fattoriale di riduzione del rischio cardio-vascolare in pazienti con diabete tipo 2: risultati a due anni dello studio MIND-IT 62
Efficacy of fluvastatin together with fenofibrate in hypercholesterolemic type 2 diabetic subjects compared to monotherapy. 62
A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome 62
Endothelial function, blood pressure control, and risk modification: impact of irbesartan alone or in combination 61
Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double-blind, clinical trial 61
Effects of aliskiren on QT duration and dispersion in hypertensive patients with type 2 diabetes mellitus 61
Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride 61
Effect of losartan irbesartan and candesartan on platelet aggregability and fibrinolysis in type 2 diabetic hypertensive patients 61
Psyllium improves dyslipidaemia, hyperglycaemia and hypertension, while guar gum reduces body weight more rapidly in patients affected by metabolic syndrome following an AHA Step 2 diet 61
Differenti effetti di candesartan e olmesartan sui parametri di attività del tessuto adiposo in pazienti diabetici di tipo 2 ipertesi 61
L’ecocardiografia da stress con dipiridamolo per la scoperta della cardiopatia ischemica valutata angiograficamente nei pazienti diabetici di tipo 2 asintomatici: risultati preliminari dello studio SEDIA (Stress Echo in DIAbetes) 61
Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with euglycemic clamp and oral fat load 61
Il controllo del paziente diabetico nello studio medico 61
Prevalence of erectile dysfunction in males affected by type 2 diabetes and the impact of hyperinsulinemia 61
Hypoglycemia, its implications in the clinical practice, and possible ways to prevent it. 61
Effetto della combinazione valsartan-amlodipina sulla funzione cognitiva in pazienti ipertesi anziani 61
Totale 7.150
Salva come PNG Salva come JPEG
Categoria #
all - tutte 138.238
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.238
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.041 0 0 0 0 5 553 81 516 9 697 165 15
2020/20214.687 575 461 122 474 8 619 19 789 133 729 628 130
2021/20222.603 28 7 124 17 11 13 30 162 135 45 480 1.551
2022/20238.600 942 532 47 615 1.009 917 7 537 3.523 96 259 116
2023/20242.641 259 500 95 195 353 653 65 256 28 84 61 92
2024/20251.569 76 807 270 280 136 0 0 0 0 0 0 0
Totale 34.425